Clinical decision support to improve management of diabetes and dysglycemia in the hospital: a path to optimizing practice and outcomes
Open Access
- 18 January 2021
- journal article
- research article
- Published by BMJ in BMJ Open Diabetes Research & Care
- Vol. 9 (1), e001557
- https://doi.org/10.1136/bmjdrc-2020-001557
Abstract
Introduction Innovative approaches are needed to design robust clinical decision support (CDS) to optimize hospital glycemic management. We piloted an electronic medical record (EMR), evidence-based algorithmic CDS tool in an academic center to alert clinicians in real time about gaps in care related to inpatient glucose control and insulin utilization, and to provide management recommendations. Research design and methods The tool was designed to identify clinical situations in need for action: (1) severe or recurrent hyperglycemia in patients with diabetes: blood glucose (BG) ≥13.88 mmol/L (250 mg/dL) at least once or BG ≥10.0 mmol/L (180 mg/dL) at least twice, respectively; (2) recurrent hyperglycemia in patients with stress hyperglycemia: BG ≥10.0 mmol/L (180 mg/dL) at least twice; (3) impending or established hypoglycemia: BG 3.9–4.4 mmol/L (70–80 mg/dL) or ≤3.9 mmol/L (70 mg/dL); and (4) inappropriate sliding scale insulin (SSI) monotherapy in recurrent hyperglycemia, or anytime in patients with type 1 diabetes. The EMR CDS was active (ON) for 6 months for all adult hospital patients and inactive (OFF) for 6 months. We prospectively identified and compared gaps in care between ON and OFF periods. Results When active, the hospital CDS tool significantly reduced events of recurrent hyperglycemia in patients with type 1 and type 2 diabetes (3342 vs 3701, OR=0.88, p=0.050) and in patients with stress hyperglycemia (288 vs 506, OR=0.60, pConclusion EMR CDS was successful in reducing hyperglycemic events among hospitalized patients with dysglycemia and diabetes, and inappropriate insulin use in patients with type 1 diabetes.Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (5K23DK107914-05)
- Eberly Medical Research Innovation Fund (N/A)
This publication has 37 references indexed in Scilit:
- Diabetes mellitus e intolerância à glicose são subdiagnosticados nas unidades de terapia intensivaRevista Brasileira de Terapia Intensiva, 2012
- Clinical decision support systems in the care of inpatients with diabetes in non‐critical care setting: systematic reviewDiabetic Medicine, 2012
- Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery)Diabetes Care, 2011
- American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic ControlDiabetes Care, 2009
- Intensive versus Conventional Glucose Control in Critically Ill PatientsThe New England Journal of Medicine, 2009
- Perceptions of resident physicians about management of inpatient hyperglycemia in an urban hospitalJournal of Hospital Medicine, 2009
- Barriers to Hyperglycemia Control in Hospitalized Patients: a Descriptive Epidemiologic StudyEndocrine Practice, 2008
- Beliefs About Hospital Diabetes and Perceived Barriers to Glucose Management Among Inpatient Midlevel PractitionersThe Diabetes Educator, 2008
- Diabetes care in hospitalized noncritically ill patients: More evidence for clinical inertia and negative therapeutic momentumJournal of Hospital Medicine, 2007
- Intensive Insulin Therapy in Critically Ill PatientsThe New England Journal of Medicine, 2001